REQUEST A DEMO
Total
USD $0.00
Search more companies

Q Bioscience Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Q Bioscience Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Q Bioscience Company Limited is a company in Thailand, with a head office in Nonthaburi. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on June 01, 2026. The total number of employees is currently 80 (estimated). From the latest financial highlights, Q Bioscience Company Limited reported a net sales revenue drop of 1.13% in 2024. During that time, Q Bioscience Company Limited’s total assets grew by 1.88%. The net profit margin of Q Bioscience Company Limited increased by 3.95% in 2024.

Headquarters
18 Soi Ngamwongwan 27 Yaek 12, Ngamwongwan Road
Nonthaburi; Central Thailand; Postal Code: 11000

Contact Details: Purchase the Q Bioscience Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Q Bioscience Company Limited report to view the information.
Financial Auditors:
Purchase the Q Bioscience Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Q Bioscience Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-1.13%
Total Operating Revenue
0.31%
Operating Profit
119.2%
EBITDA
119.2%
Net Profit/Loss for the Period
185.6%
Total Assets
1.88%
Total Equity
13.42%
Operating Profit Margin
4.89%
Net Profit Margin
3.95%
Return on Equity (ROE)
8.61%
Debt / Equity
6.44%
Quick Ratio
-0.03%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?